ArticleJournal of inflammation research2025
Intestinal Microbiota Dysbiosis Disrupts the Mucosal Barrier, Triggering Inflammatory Responses in Gut-Kidney Interaction and Exacerbating Diarrhea.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Article
- Associations of Inosine with Gut Microbiota, Metabolic Indicators, and Fluid Homeostasis in Kidney-Related Diarrhea.International journal of molecular sciences · 2026Article
- Effects of Dietary Standardized Ileal Digestible Lysine and Amylose/Amylopectin Ratio on Intestinal Morphology, Barrier-Related Gene Expression, and Cecal Microbiota in Broilers Fed Low-Protein Diets.Animals : an open access journal from MDPI · 2026Article
- The Role and Potential Mechanism of Pectin and Pectin Oligosaccharides in Treating Intestinal Inflammation by Regulating Gut Microbiota.Probiotics and antimicrobial proteins · 2026Review
- The Interplay Among Gut Microbial Composition, Short-Chain Fatty Acid Metabolism and Gut-Kidney Oxidative Stress: Correlation with Diarrhea.Journal of inflammation research · 2026Article
- Gut microbiota and kidney aging: insights into current research.Nutrition & metabolism · 2025Review
- The role of gut microbiota in myocardial ischemia-reperfusion injury.Frontiers in cardiovascular medicine · 2025Review
- Commentary: Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation.Frontiers in cellular and infection microbiology · 2025Article
- Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation.Frontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Intestinal microbiota dysbiosis is observed in diarrhea with kidney-yang deficiency syndrome. Therefore, this study will explore the mechanisms by which intestinal microbiota dysbiosis contributes to the initiation and progression of this condition. Methods: Thirty SPF-grade male KM mice were randomly assigned to three groups: the control group, the diarrhea with kidney-yang deficiency syndrome model group, and the intestinal microbiota dysbiosis + diarrhea with kidney-yang deficiency syndrome model group. After the modeling period, samples were collected. HE staining was employed to observe pathological changes in the colon and kidneys. Detect and analyze the functions of the colonic mucosal barrier and renal function. Measure the levels of NOD-like receptor family pyrin domain containing protein 3 (NLRP3) inflammasome-related molecules and inflammatory factors in the colon and kidney tissues. 16S rRNA sequencing combined with bioinformatics analysis was employed to evaluate the diversity and species composition of the intestinal microbiota, conduct correlation analysis, and predict its metabolic functions. Results: The model mice exhibited increased fecal water content and decreased body temperature. Structural damage was observed in both the colon and kidney tissues. The intestinal mucosal barrier function was impaired. Furthermore, elevated levels of NLRP3 inflammasome-related molecules and inflammatory cytokines were observed in both colon and kidney tissues. Additionally, alterations were noted in the microbial community structure of the colon contents, characterized by decreased richness, diversity, and evenness. Finally, correlation analysis revealed a significant positive correlation between the characteristic bacterium Conclusion: Intestinal microbiota dysbiosis leads to a decline in intestinal mucosal barrier function, accompanied by inflammatory responses and pathological changes in both colonic and renal tissues, resulting in gut-kidney interaction damage. Collectively, these changes promote the development of diarrhea with kidney-yang deficiency syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.